Found: 163
Select item for more details and to access through your institution.
Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 7, p. 829, doi. 10.1111/iju.15449
- By:
- Publication type:
- Article
Editorial Comment to Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 7, p. 831, doi. 10.1111/iju.15458
- By:
- Publication type:
- Article
Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-00973-7
- By:
- Publication type:
- Article
Evaluating first-line therapeutic strategies for metastatic castration-resistant prostate cancer: a comprehensive network meta-analysis and systematic review.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1378993
- By:
- Publication type:
- Article
Fine-tuning the activation behaviors of ternary modular cabazitaxel prodrugs for efficient and on-target oral anti-cancer therapy.
- Published in:
- Asian Journal of Pharmaceutical Sciences, 2024, v. 19, n. 2, p. 1, doi. 10.1016/j.ajps.2024.100908
- By:
- Publication type:
- Article
Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1366, doi. 10.3390/cancers16071366
- By:
- Publication type:
- Article
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. 185, doi. 10.1093/oncolo/oyad344
- By:
- Publication type:
- Article
Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5273, doi. 10.3390/cancers15215273
- By:
- Publication type:
- Article
Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review.
- Published in:
- World Journal of Men's Health, 2023, v. 41, n. 4, p. 769, doi. 10.5534/wjmh.220200
- By:
- Publication type:
- Article
Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4511, doi. 10.3390/cancers15184511
- By:
- Publication type:
- Article
Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3969, doi. 10.3390/cancers15153969
- By:
- Publication type:
- Article
Facile fabrication of silk sericin-coated zeolitic imidazolate framework-8 nanocarriers encapsulating cabazitaxel for the treatment of liver cancer cells and their cell death mechanism.
- Published in:
- Journal of Materials Science, 2023, v. 58, n. 25, p. 10441, doi. 10.1007/s10853-023-08605-1
- By:
- Publication type:
- Article
Dose Optimization in Oncology Drug Development: The Emerging Role of Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3233, doi. 10.3390/cancers15123233
- By:
- Publication type:
- Article
Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10998-w
- By:
- Publication type:
- Article
Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening.
- Published in:
- Scientific Reports, 2023, p. 1, doi. 10.1038/s41598-023-35950-7
- By:
- Publication type:
- Article
Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1157306
- By:
- Publication type:
- Article
STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6643, doi. 10.3390/ijms24076643
- By:
- Publication type:
- Article
The regulatory effect of cabazitaxel on epithelial-mesenchymal transition in metastatic prostate cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, p. S306, doi. 10.4103/jcrt.jcrt_364_21
- By:
- Publication type:
- Article
Cabazitaxel's ototoxicity: An animal study and histopathologic research.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, p. S314, doi. 10.4103/jcrt.jcrt_774_21
- By:
- Publication type:
- Article
The efficacy of sequential therapy with docetaxel and cabazitaxel for castration‐resistant prostate cancer: A retrospective multi‐institutional study in Japan.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 2, p. 227, doi. 10.1111/iju.15097
- By:
- Publication type:
- Article
Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 503, doi. 10.1159/000530547
- By:
- Publication type:
- Article
Efficacy of cabazitaxel in patients with metastatic castration‐resistant prostate cancer: A single‐center study in Japan.
- Published in:
- International Journal of Urology, 2023, v. 30, n. 1, p. 20, doi. 10.1111/iju.15052
- By:
- Publication type:
- Article
Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 262, doi. 10.3390/pharmaceutics15010262
- By:
- Publication type:
- Article
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 642, doi. 10.1111/ajco.13732
- By:
- Publication type:
- Article
2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
- Published in:
- Canadian Urological Association Journal, 2022, v. 16, n. 11, p. E506, doi. 10.5489/cuaj.8161
- By:
- Publication type:
- Article
An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2022, v. 49, n. 10, p. 1094, doi. 10.1111/1440-1681.13694
- By:
- Publication type:
- Article
An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Stability study of concentrate-solvent mixture & infusion solutions of Jevtana® cabazitaxel for extended multi-dosing.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1035, doi. 10.1177/10781552211016079
- By:
- Publication type:
- Article
A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2022, v. 8, n. 4, p. 1, doi. 10.1101/mcs.a006194
- By:
- Publication type:
- Article
The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling.
- Published in:
- Molecular Biology Reports, 2022, v. 49, n. 6, p. 4873, doi. 10.1007/s11033-022-07343-y
- By:
- Publication type:
- Article
Safety and survival of docetaxel and cabazitaxel in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2022, v. 129, n. 4, p. 470, doi. 10.1111/bju.15542
- By:
- Publication type:
- Article
Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro.
- Published in:
- Molecular Biology Reports, 2022, v. 49, n. 2, p. 1261, doi. 10.1007/s11033-021-06953-2
- By:
- Publication type:
- Article
The Activation of PI3K/AKT/mTOR Signaling Pathway in Response to Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer Cells.
- Published in:
- European Journal of Biology, 2021, v. 80, n. 2, p. 138, doi. 10.26650/EurJBiol.2021.1018938
- By:
- Publication type:
- Article
Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway.
- Published in:
- FEBS Open Bio, 2021, v. 11, n. 11, p. 3032, doi. 10.1002/2211-5463.13290
- By:
- Publication type:
- Article
Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-01048-3
- By:
- Publication type:
- Article
Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6304, doi. 10.1002/cam4.4172
- By:
- Publication type:
- Article
Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 3, p. 525, doi. 10.1007/s00280-021-04304-3
- By:
- Publication type:
- Article
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 9, p. 1745, doi. 10.1007/s10147-021-01956-2
- By:
- Publication type:
- Article
Circulating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4055, doi. 10.3390/cancers13164055
- By:
- Publication type:
- Article
Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
- Published in:
- American Journal of Case Reports, 2021, v. 22, p. 1, doi. 10.12659/AJCR.930989
- By:
- Publication type:
- Article
Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells.
- Published in:
- Human & Experimental Toxicology, 2021, v. 40, n. 7, p. 1122, doi. 10.1177/0960327120984209
- By:
- Publication type:
- Article
Targeting Nrf2-antioxidant signalling reverses acquired cabazitaxel resistance in prostate cancer cells.
- Published in:
- Journal of Biochemistry, 2021, v. 170, n. 1, p. 89, doi. 10.1093/jb/mvab025
- By:
- Publication type:
- Article
Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration‐resistant prostate cancer: A local experience of a multicenter retrospective study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 3, p. 238, doi. 10.1111/ajco.13441
- By:
- Publication type:
- Article
Management of Genitourinary Malignancies.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 356
- Publication type:
- Article
Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 5, p. e2110950, doi. 10.1001/jamanetworkopen.2021.10950
- By:
- Publication type:
- Article
Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.
- Published in:
- In Vivo, 2021, v. 35, n. 3, p. 1703, doi. 10.21873/invivo.12430
- By:
- Publication type:
- Article
Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87758-y
- By:
- Publication type:
- Article
Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 4, p. 419, doi. 10.1080/0284186X.2021.1881818
- By:
- Publication type:
- Article
Malignant Pleural Mesothelioma Interactome with 364 Novel Protein-Protein Interactions.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1660, doi. 10.3390/cancers13071660
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 4, p. 15
- By:
- Publication type:
- Article